{"schema_version":"secwatch.filing_event.v1","accession":"0000200406-26-000155","form_type":"8-K","ticker":"JNJ","cik":"0000200406","company_name":"JOHNSON & JOHNSON","filed_at":"2026-07-28T00:15:31+00:00","discovered_at":"2026-07-28T10:05:00.380547+00:00","generated_at":"2026-07-28T10:05:06.008412+00:00","sec_items":["7.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Johnson & Johnson agrees to $5.5B comprehensive resolution of ovarian talc litigation","bullets":["Agreement with plaintiff firms leading federal MDL and state court proceedings, conditioned on at least 95% participation of remaining claims.","$5.5 billion total commitment; first payment of up to $3 billion in 2027, no further payments before 2028.","Per claim payment structure under the comprehensive resolution.","Resolution covers ovarian talc litigation, a major ongoing legal matter for JNJ."],"urls":{"canonical":"https://secwatch.observer/filing/0000200406-26-000155","json":"https://secwatch.observer/filing/0000200406-26-000155.json","markdown":"https://secwatch.observer/filing/0000200406-26-000155.md","text":"https://secwatch.observer/filing/0000200406-26-000155.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000155/0000200406-26-000155-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000155/jnj-20260727.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-28T10:05:06.008412+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}